Intracoronary versus intravenous glycoprotein IIb/IIIa inhibitors during primary percutaneous coronary intervention in patients with STEMI: a systematic review and meta-analysis. [PDF]
Thromb J, 2023 Hahn J +7 more
europepmc +1 more source
An Ionic Contrast Agent Inhibits Platelet-dependent Thrombin Generation and Boosts the Effect of Abciximab [PDF]
, 2001 Raed Al Died +3 more
openalex +1 more source
Vitae, 2009 Las Enfermedades Cardiovasculares son la principal causa de muerte en el mundo. Junto con los esfuerzos en disminuir los factores de riesgo cardiovascular, se recurre a diversos medicamentos para disminuir la morbimortalidad asociada a estas enfermedades,
Iván F PALOMO G +4 more
doaj
A Case of Successful Primary Coronary Intervention for the Total Occlusion of Left Main Stem with the Aid of Abciximab [PDF]
, 2001 Myung Ho Jeong +10 more
openalex +1 more source
Rescue use of abciximab improves regional left ventricular function after early incomplete reperfusion in acute myocardial infarction [PDF]
, 2001 Goo‐Yeong Cho +7 more
openalex +1 more source
The long and winding road: the management of Acute Coronary Syndromes in Malta [PDF]
, 2003 The treatment of acute coronary syndromes in Malta has been revolutionized over the past decade by the introduction of the catheterization laboratory. With the set-up of on-call cardiac invasive teams for primary percutaneous coronary interventions in ST-
Xuereb, Mariosa, Xuereb, Robert G.
core
Abciximab-induced acute profound thrombocytopenia postpercutaneous coronary intervention
BMJ Case Reports, 2017 Todd Golden +3 more
semanticscholar +1 more source
CD2: ABCIXIMAB IN PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY: A MULTICENTER OBSERVATIONAL STUDY
, 1999 Vlasses Ph +5 more
openalex +1 more source